1 / 6

Autoimmune Drugs Market Trends, Challenges and Growth Drivers Analysis 2020

The analysts forecast global autoimmune diseases drugs market to grow at a CAGR of 5.57% during the period 2016-2020. Autoimmune diseases occur due to genetic, infectious, or environmental factors. There are over 80 autoimmune diseases, including AS, IBD (CD and UC), MS, RA, SLE, and PsA. DMARDs, NSAIDs, corticosteroids, analgesics, and immunosuppressants are the major drug classes used to treat autoimmune diseases.

jayram
Download Presentation

Autoimmune Drugs Market Trends, Challenges and Growth Drivers Analysis 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Autoimmune Drugs Market 2016-2020 Single User License: US$ 2500 No of Pages: 137 Corporate User License: US$ 4000 www.rnrmarketresearch.com WEBSITE

  2. Global Autoimmune Drugs Market 2016-2020 The analysts forecast global autoimmune diseases drugs market to grow at a CAGR of 5.57% during the period 2016-2020.  Autoimmune diseases are immunological disorders that occur when the immune system attacks and destroys healthy tissues in the body rather than foreign bodies, causing significant pain, inflammation, and organ damage. These diseases can affect the nervous system, cardiovascular system, and musculoskeletal system or individual organs, including the skin, lungs, kidneys, glands, and joints.  Autoimmune diseases occur due to genetic, infectious, or environmental factors. There are over 80 autoimmune diseases, including AS, IBD (CD and UC), MS, RA, SLE, and PsA. DMARDs, NSAIDs, corticosteroids, analgesics, and immunosuppressants are the major drug classes used to treat autoimmune diseases.  ViewComplete Report @ http://www.rnrmarketresearch.com/global-autoimmune-drugs-market-2016-2020- market-report.html

  3. Global Autoimmune Drugs Market 2016-2020 The report covers the present scenario and the growth prospects of the global autoimmune diseases drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of autoimmune diseases.  The market is divided into the following segments based on geography: Americas, APAC, EMEA  The report, Global Autoimmune Diseases Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.  Purchase a Copy of this Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=514421

  4. Global Autoimmune Drugs Market 2016-2020 Key vendors : AbbVie Inc., Amgen Inc., Biogen, F. Hoffmann-La Roche, Johnson & Johnson Private Limited, and Pfizer Inc. Other prominent vendors : Ablynx, AB Science, Acorda Therapeutics, Alder BioPharmaceuticals, Antares Pharma, Astellas Pharma, AstraZeneca, Baxter, Boehringer Ingelheim, Can-Fite BioPharma, Celgene, Celltrion, ChemoCentryx, Coherus BioSciences, Daiichi Sankyo, Eisai, Eli Lilly, Gilead Sciences, GSK, Hospira, Idera Pharmaceuticals, Immunomedics, ImmuPharma, Incyte, Invion, KaloBios Pharmaceuticals, Lexicon Pharmaceuticals, Merck, MedImmune, Morphotek, Novo Nordisk, Novartis, Opexa Therapeutics, Principia Biopharma, Regeneron Pharmaceuticals, Sandoz, Sanofi, Santarus, Takeda Pharmaceuticals, UCB, Vaccinex, Vertex Pharmaceuticals and Vitae Pharmaceuticals. Market driver - Promising pipeline Market challenge - Loss of patent exclusivity of branded therapies Market trend - Increase in public awareness programs Inquire on the Report @ http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=514421 .

  5. Global Autoimmune Drugs Market 2016-2020 Key questions answered in this report What will the market size be in 2020 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=514421

  6. RNR MARKET RESEARCH RNRMARKETRESEARCH.COM, An online repository of market research reports, offers in-depth analysis of over 5000 market segments. RNR market research library has syndicated reports by leading market research publishers across the globe. For more details contact : sales@rnrmarketresearch.Com / +18883915441 FOLLOW US Website www.rnrmarketresearch.com

More Related